NasdaqCM - Nasdaq Real Time Price USD
Elicio Therapeutics, Inc. (ELTX)
5.22
+0.17
+(3.37%)
At close: April 23 at 4:00:01 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
44,986
44,986
35,745
23,733
25,474.69
Operating Income
-44,986
-44,986
-35,745
-23,733
-25,474.69
Net Non Operating Interest Income Expense
-3,180
-3,180
-686
-3,532
-873.05
Other Income Expense
-3,732
-3,732
1,236
-943
-52.96
Pretax Income
-51,898
-51,898
-35,195
-28,208
-26,400.70
Net Income Common Stockholders
-51,898
-51,898
-35,195
-28,208
-26,400.70
Diluted NI Available to Com Stockholders
-51,898
-51,898
-35,195
-28,208
-26,400.70
Basic EPS
-4.25
-4.25
-6.96
-2.70
-2.52
Diluted EPS
-4.25
-4.25
-6.96
-2.70
-2.52
Basic Average Shares
12,203
12,203
5,056.23
10,463.80
10,463.80
Diluted Average Shares
12,203
12,203
5,056.23
10,463.80
10,463.80
Total Operating Income as Reported
-44,986
-44,986
-35,745
-23,733
-25,474.69
Total Expenses
44,986
44,986
35,745
23,733
25,474.69
Net Income from Continuing & Discontinued Operation
-51,898
-51,898
-35,195
-28,208
-26,400.70
Normalized Income
-48,166
-48,166
-36,431
-27,265
-26,347.74
Interest Income
777
777
373
65
3.39
Interest Expense
455
455
1,059
3,597
876.44
Net Interest Income
-3,180
-3,180
-686
-3,532
-873.05
EBIT
-51,443
-51,443
-34,136
-24,611
-25,524.26
EBITDA
-50,265
-50,265
-32,966
-23,554
-25,272.81
Reconciled Depreciation
1,178
1,178
1,170
1,057
251.45
Net Income from Continuing Operation Net Minority Interest
-51,898
-51,898
-35,195
-28,208
-26,400.70
Total Unusual Items Excluding Goodwill
-3,732
-3,732
1,236
-943
-52.96
Total Unusual Items
-3,732
-3,732
1,236
-943
-52.96
Normalized EBITDA
-46,533
-46,533
-34,202
-22,611
-25,219.84
12/31/2021 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IVA Inventiva S.A.
3.9100
+2.89%
SER Serina Therapeutics, Inc.
5.78
+5.09%
AMPE Ampio Pharmaceuticals, Inc.
0.0021
0.00%
688177.SS Bio-Thera Solutions, Ltd.
21.72
-1.54%
HTD.MU Corcept Therapeutics Inc
60.20
+5.73%
IVEVF Inventiva S.A.
2.2800
0.00%
BT3.BE Lineage Cell Therapeutics Inc
0.4020
+8.06%
HQ1.MU Oruka Therapeutics Inc. R
9.15
+0.55%
NXOA.BE Nicox SA
0.2280
+0.88%
GON.DU Geron Corp
1.2080
-1.31%